All News

Richard Conway Tweet
RichardPAConway
Dr Doliner @zach_wallace_md on ILD in AAV. ILD in 13% - of which 76% fibrotic. UIP most common. Most MPO+, but also rarely seen with PR3+. 47% ⬆️ risk of death. Abstr#0430 #ACR21 @RheumNow https://t.co/6MnxqW92bz
Richard Conway Tweet
RichardPAConway
Dr McDermott @jeffsparks on risk factors for RA-bronchiectasis. Seropositivity, older age at RA onset, and lower BMI⬆️risk. Abstr#0288 #ACR21 @RheumNow https://t.co/7d2ZVWLzn6
Ashima Makol MD Tweet
AshimaMakol
🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler ✨MMF likely to stay 1st line, then Nintedanib ❓Is it time for MMF + Antifibrotic upfront?? Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc
swethaann23 Tweet
swethaann23
Among 6 CV risk algorithms, the best to predict the carotid plaque (CP) in PsA is the ACC/AHA risk score showed an AUC 0.681 (0.551-0.812), p=0.008, a cut-off point ≥4.8, sensitivity of 63.6%, and specificity of 64.4% ⭐️Prevalence CP 42.3% Abst #1315 #ACR21 @RheumNow https://t.co/hRvyjetYq3
Bella Mehta Tweet
bella_mehta
Pulmonary Arterial Hypertension in #AOSD Rare but severe complication - life threatening French study of 13 pts - network dataset. ALL FEMALES! Age 32, mean f/u 34 mths, 5 pts (38.5%) DIED @RheumNow #ACRBest abst#1100 https://t.co/5LIzHagesP
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Knowledge Bowl at #ACR21 ⭐️The first lung fibrosis described in Sjogren's with lung biopsy showing benign polyclonal lymphocytes and plasma cells with a risk for malignant transformation. ➡️Lymphocytic Interstitial Pneumonia @RheumNow
Mrinalini Dey Tweet
DrMiniDey
Almost like real-life, I've "run across the conference centre" to catch the end of the #InterstitialLungDisease session- some excellent insights from Dr Melissa Griffith on a complex topic, will definitely be reviewing the full talk later. #ACR21 @RheumNow https://t.co/LdhXI8LLqY
David Liew Tweet
drdavidliew
Steroids can cause co-morbidities which increase CV risk, but can PNL directly increase CV event (MACE) risk in RA? 30d PNL➡️15% increase in MACE in next 30d (independent of underlying CV risk, RA dx activity) PNL actively confers risk! @BethIWallace #ACR21 ABST1428 @RheumNow https://t.co/cuL69n7cx3
Bella Mehta Tweet
bella_mehta
26K Veterans data with RA #ACR21 plenary abst#1428 30 days on glucocorticoids - ⬆️15% odds of Major Adverse Cardiovascular events @RheumNow @BethIWallace https://t.co/BOram4o2rp
Mrinalini Dey Tweet
DrMiniDey
Plenary Abs#1427 #ACR21 👉🏼#Statins assoc w/ reduced #CVD & all-cause mortality, outweighing modest #T2DM risk increase in RA pts 👉🏼Reduction in all-cause mortality greater in RA than gen population 👉🏼Incr in T2DM risk is NOT greater in RA compared to gen population @RheumNow https://t.co/WcF11B0C2s
Bella Mehta Tweet
bella_mehta
Statins in RA - plenary at #ACR21 UK Clinical Practice Research Datalink 1989-2018 @RheumNow Reduction in CVD risk, All cause mortality INCREASE in Type 2 DM risk🧐 - need to make sure we look into it for RA patients! Great work @UNMC_Rheum by Gulsen Ozen! https://t.co/YmTO0xcdjj
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×